Purpose Adolescent Idiopathic Scoliosis (AIS) is considered a complex genetic disease, in which malfunctioning or dysregulation of one or more genes has been proposed to be responsible for the expressed phenotype. However, to date, no disease causing genes has been identified and the pathogenesis of AIS remains unknown. The aim of this study is, therefore, to identify specific molecules with differing expression patterns in AIS compared to healthy individuals. Methods Microarray analysis and quantitative RT-PCR have examined differences in the gene transcription profile between primary osteoblasts derived from spinal vertebrae of AIS patients and those of healthy individuals. Results There are 145 genes differentially expressed in AIS osteoblasts. A drastic and significant change has been noted particularly in the expression levels of Homeobox genes (HOXB8, HOXB7, HOXA13, HOXA10) , ZIC2, FAM101A, COMP and PITX1 in AIS compared to controls. Clustering analysis revealed the interaction of these genes in biological pathways crucial for bone development, in particular in the differentiation of skeletal elements and structural integrity of the vertebrae.
Introduction
Idiopathic Scoliosis (IS) is characterized by a threedimensional deformity of the spine and its incidence in the general population ranges from 0.15 to 4 % [1] . Adolescent IS (AIS) accounts for 80 % of IS [2] . The origin and cause of AIS remains unknown to date but there are several proposed etiological hypotheses [3] including melatonin deficiency [4] or signaling defect [5] , connective tissue abnormalities [6] , asymmetries in the central nervous system [7] . abnormal distribution and interaction between melatonin and calmodulin [5, 8] hormonal variation [9] , diet, and posture. In addition, there is strong evidence of genetic predisposition to AIS. For instance, familial occurrences of AIS have been reported by many research groups, and concordance for this condition in twins' studies further strengthens the genetic influence on the etiology of AIS. However, controversy exists as to whether the mode of inheritance is multifactorial trait an autosomal dominant trait, or even an X-linked dominant trait. AIS is considered as a complex genetic disease, in which one or more genes may be responsible for the expressed phenotype, and in which several modifying effects, such as age, sex, and environment, may play specific roles in the phenotypic variation between affected individuals; it is most likely premature to assign responsibility to a single gene.
Recently, chromosomal regions on 6, 10 and 18q [10] , 17p11.2, 19p13.3, Xq23-26.1, 8q11, 9q31.2-q34.2, 17q25.3-qtel, 12p13.31 and recently 3q12.1 and 5q13.3 [11] have been associated with AIS. Even genome-wide association studies (GWAS) have recently been used to study genetic predisposition for AIS and although polymorphisms associated with AIS have been described in SNTG1 on 8q11.22, ESR1 on 6q25.1, MATN1 on 1p35, CHD7 on 8q12.1, MTNR1B on 11q21-q22 and CHL1 [12] , no specific genes or proteins have been identified as players in the development of scoliosis. Therefore to gain an insight into the pathogenesis of AIS, we used a microarray approach to study specific alterations in the genetic expression profile of AIS osteoblasts. Our microarray results show that specific subsets of genes are differentially expressed in AIS, which was confirmed for the most part by reverse-transcription-quantitative PCR (RT-qPCR). Furthermore, we observe that the differentially regulated genes could be grouped and assigned to various functional categories, indicating that many regulatory pathways could be involved in AIS pathogenesis.
Materials and methods

Patients
Six unrelated individuals with AIS, and six controls (non-AIS individuals), all French-Canadian females from Quebec were studied. They were examined by the Adam's test and by a standing upright radiograph of the spine. Two independent blinded orthopedic surgeons read the X-rays (clinical features of patients, Table 1 ). All AIS patients were selected by the same criteria, namely the spinal deformity was a right-thoracic progressive curve requiring corrective spinal surgery. The Cobb angle ranged between 30°and 84°. For the control patients, spinal deformity was excluded by X-ray and clinical examination: they were subjected to spine surgery for traumatic injury. For the experimental design, we choose individuals with the same features for each group to get homogeneous populations. Bone fragments excised during surgery were used to isolate osteoblasts as described below. Each participating subject or, in the case of minors, their legal guardian, gave informed consent. The research protocol was approved by the Research Ethics Committee of Sainte-Justine Hospital.
Primary human osteoblast culture and RNA extraction Briefly, bone fragments were cultivated in alpha-MEM (supplemented with 10 % (v/v) fetal bovine serum (FBS, Wisent) and 2 mM glutamine, with 100 U/mL penicillin and 100 lg/mL streptomycin (Invitrogen, Burlington, ON, Canada) as antibiotics) at 37°C. 5 % CO 2 for a period of 28 days, after which the osteoblasts derived from the bone pieces were separated from the remaining bone fragments by trypsinization. To confirm the osteoblasts phenotype, cells were stained for alkaline phosphatase, osteocalcin, osteopontin and collagen type I as we previously described in Letellier et al. [13] . RNA was extracted from osteoblasts using TRIzol Reagent (Invitrogen), according to the manufacturer's instructions, and verification of RNA integrity and concentration were carried out with the Agilent Bioanalyzer 2100 in concert with the Agilent RNA 6,000 nano or pico kit (Agilent) (RNA Quality Testing Services, McGill University and Génome Québec Innovation Centre Montréal Canada).
Microarray gene expression profiling RNA samples were analyzed using 12 individual Illumina Human HT-12 v3 BeadChip microarrays, which contain probes for 48,804 unique gene expression sequences (from NCBI RefSeq build 38). with 99.99 % coverage specification. Preparatory cDNA synthesis and labeling. microarray hybridization reactions, and data collection were performed according to established protocols at the McGill University and Génome Québec Innovation Centre. Microarray expression data were subsequently analyzed using the FlexArray software (version 1.6.1) a front-end to R and Bioconductor. Probe intensity data were normalized across replicate arrays by robust multi-array average (RMA) and differential gene expression was calculated by empirical Bayes analyses of microarrays (EBAM) with Benjamini-Hochberg false-discovery rate (FDR) correction. Gene expression profiles from primary osteoblasts derived from spinal vertebrae of AIS patients (All AIS with right thoracic curve; n = 6) were compared with profiles from the same cells collected from age and sex-matched healthy individuals (n = 6). Microarray analysis was conducted on six AIS-Control sample pairs and the data were normalized. To determine those genes that were differentially expressed between AIS cells and control cells, foldchanges between AIS and control cells were calculated. All values were expressed as positive or negative fold changes. Genes that were differentially expressed [1.5-fold, relative to control patient levels, were considered as differentially regulated. Significance analyses of microarrays (SAM) algorithm were then used to calculate FDR-adjusted q-values according to the method of Storey; q-values\0. 15 were considered statistically significant.
Functional classification clustering
To compare similarities in gene function in our list of differentially regulated genes, we used the Database for Annotation, Visualization, and Integrated Discovery (DAVID) functional gene clustering algorithm (version 6.7). 145 differentially regulated genes were selected based on our criteria as set forth, and this list was uploaded to the DAVID functional gene clustering web interface. The software compares the uploaded gene list to a gene-gene similarity matrix of over 75,000 functional annotation terms, and generates a cluster map of functionally similar genes using fuzzy heuristic partitioning.
Hierarchical clustering
To reveal potential gene-gene associations in our expression data, we performed hierarchical clustering analysis using Cluster 3.0 software. Briefly, we loaded our list of 145 differentially regulated genes, with the corresponding difference in fold change (as determined above), into the software. We then performed hierarchical clustering calculations using Euclidean distance as a similarity metric, with average linkage as the clustering method. The resulting dendrogram was visualized using Java TreeView (version 1.1.5r2).
Reverse-transcription quantitative PCR
To provide confirmation for our microarray results, the expression levels of a subset of up-and down-regulated genes (in AIS osteoblasts. compared to controls) were evaluated by RT-qPCR analysis. Quantitative PCR was performed for the following genes, selected from the list of genes with the highest fold-changes and those which seem interesting from clustering and functional analysis results. Table 2 displays the primers sequences. Total RNA was prepared from osteoblasts from three AIS patients and from three controls, as described above. Reverse transcription, using poly-deoxythymidine oligos (Invitrogen) as transcription primers, was then performed on 500 ng of RNA that had been treated with ribonuclease-free deoxyribonuclease I (Invitrogen). Quantitative PCR was performed, using SYBR GREEN chemistry as a marker for DNA amplification, on an ABI Prism 7900HT fast real-time PCR system, with 40 cycles of a stepwise amplification (once for 2 min at 50°C, once for 10 min at 95°C, 40 times for 15 s at 95°C, followed by measurement for 1 min at 60°C). Dissociation curve analysis was performed to ensure product specificity. The fold change of expression was calculated in relation to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal reference gene, and the expression level was then determined relative to control osteoblasts. Amplification plots, dissociation curves, and threshold cycle (Ct) values were generated by ABI Sequence Detection System software (version 2.4) after data collection, and expression fold-changes were calculated for each gene by the delta-delta Ct method. Individual genes were compared in between AIS patients and controls using Student's t test.
Results
Microarray gene expression
To screen for candidate genes that may contribute to the pathogenesis of AIS, we comparatively analyzed the gene expression patterns of AIS osteoblasts and healthy osteoblasts by microarray analysis. A scatter plot of the microarray data revealed significant gene expression changes in 145 genes in AIS osteoblasts, as compared to controls ( Fig. 1 ; n = 6, empirical Bayes, p \ 0.05). Among these 145 genes, 86 were up-regulated [1.5-fold, such as HOXB8, HOXB7, HOXB5, FLJ30375, ZIC2 and ZIC4 and 59 were down-regulated [1.5-fold, such as HOXA10, HOXA13, HOXA11, FAM101A, TINAGL1, ERAP2, COMP and PITX1. A complete list of up-and down-regulated genes is provided in Table 3 . To identify biological pathways common to the differentially expressed genes in AIS osteoblasts, we performed a hierarchical clustering followed by a gene ontology (GO) analysis with DAVID (Database for Annotation, Visualization, and Integrated Discovery) on the 145 differentially expressed genes with a fold change values C1.5. Interestingly, hierarchical analysis revealed a very close genetic interaction between the down-regulated genes HOXA13 and HOXA10 genes, and between MAB21L2, BST2, EPYC, ERAP2, TINAGL1, FAM101A and HOXA11 genes (Fig. 2) . In a second cluster, EVI2A, G0S2, HOXB6, RASIP1, NGEF. MYLC2PL and HOXA2 genes were found to interact together. Among the up-regulated genes, hierarchical analysis identified one interesting cluster of a closely related genetic interaction between HOXB8 and HOXB7, HOXB5 and FLJ30375 and between ZIC2 and ZIC4 genes (Fig. 2) . GO analysis of the differentially expressed genes revealed five distinct groups based on similar molecular function and biological process (Group 1-5) ( Table 4) . NM_024016  GTC CGT GCG CGC CAA TTA TTA  GCC CGT GGT AGA ACT CGT G   HOXB7  NM_004502  CCA GCC TCA AGT TCG GTT TTC  CGC GAA CGC GCT CCA TAG   HOXB5  NM_002147  AAC TCC TTC TCG GGG CGT TAT  CAT CGCATT GTA ATT GTA GCC GT   ZIC2  NM_007129  CAC AAC CAG TAC GGC CGCATG AA  AGC TCC TGC TTG ATG CAC TGC TG   CXCL1  NM_001511  AGG GAA TTC ACC CCA AGA AC  ACT ATG GGG GA T GCA GGA TT   HOXB2  NM_002145  CGT TCC CGA CGT CAA cn CTT  CTC TTC CTC GGA AM AGG GAC   GDF15  NM_004864  CGC GGGACC CTC AGA GTT  CCG CAG CGT GGT TAG CA   DDIT4  NM_019058  AGG AAG CTC ATT GAG TTG TG  GGT ACA TGC TAC to cell-cell adhesion and calcium ion binding. The remaining ten genes in cluster group four possess homology domains implicated in cell adhesion and membrane transport. Cluster group 5 is composed of four genes, all zinc finger proteins involved in signal transduction interactions and in ion binding.
RT-qPCR validation of gene expression
To confirm the microarray results 24 genes were chosen for RT-qPCR validation. They were selected because they were the highest fold-changed and they appeared in either functional classification or clustering analyses. Similar patterns of gene expression differences were seen for all genes determined to be down-regulated by our microarray analyses (Fig. 3a, b) , thereby confirming our conclusions. Some of the up-regulated by our microarray analyses were also confirmed by RT-qPCR experiments, however no significant up-regulation was observed for HOXB7, ZIC2, SLC7A5, DDIT4, TRIB3, CBS, GDF15 and CXCL1 (Fig. 3a) .
Profiled genes versus previously reported AIS candidate regions
Several genetic linkage and genome-wide association studies have identified chromosomal loci predisposing to AIS. But to date, no genes have been clearly identified as causative in AIS. We therefore sought to identify if there were any significantly differentially regulated genes in AIS osteoblasts within the reported loci. 32 genes were identified as corresponding with previously reported AIS candidate loci (Table 5) . Within region 19p13.3 [14] , we identified two genes to be up-regulated: MKNK2 and CD70, HCLS1 and COL8A1 genes were down-regulated and F2R, F2RL2 and BHMT2 genes were up-regulated in the chromosomal regions identified by Edery et al. [11] . Within locus 1p35 [15] , TINAGL1 gene was found downregulated. Finally, in the AIS candidate region 9q31.2-q34.2 [16] , OLFML2A was up-regulated. However, none of these genes had a significant fold change C1.5 (Table 3) .
Discussion
In the present work, we have used gene expression profiling to identify differentially expressed genes in AIS compared with non-AIS osteoblasts. Our study provides a previously unrecognized list of genes and related potential pathways that merit further investigation, such as identification of variants in these genes, as putative AIS causative genes. These genes were grouped in terms of their biological function, and clustered by gene-gene interactions. We identified at least four particular pathways that might be important in AIS: the developmental/growthdifferentiation of skeletal elements (HOXB8, HOXA2,   HOXB2 , MEOX2 and PITX1); cellular signaling (HOXA11 and BARX1), connecting structural integrity of the extracellular matrix to the structural integrity of a bone or a muscle fiber (COMP, HOXA2 and HOXA11); and cellular signaling and cartilage damage (GDF15). Among the differentially expressed genes, some could act on processes directly related to the causes of AIS (associated with embryogenesis/morphogenesis), while others may play contributory roles (related to spinal deformity progression). Yet others may be condition-specific genes (differentially expressed genes as a consequence of disease).
Our results revealed that the most up-and down-regulated genes involved in the AIS pathology are members of the Homeobox (HOX) gene family. The HOX genes are, in general, implicated in the regulation of patterns of development (morphogenesis). We identified differential expression of HOXA group genes (10, 11 and 13), of HOXB group genes (2-8) and of HOXD (1) (2) (3) (4) . Interestingly, knockdown of Hoxd1 generates defects in hindbrain and neural crest derivatives [17] . The over-expression of Hoxd4 has resulted in severe cartilage defects in mice [18] , while over-expression of Hoxb8 in transgenic mouse embryos has resulted in defects in the vertebrae [19] . HOXA10 plays a key role in regulating target genes for osteoblast differentiation and bone formation in the postnatal skeleton [20] . HOXA13 gene is involved particularly in segment identity specification along the limb axis in vertebrates [21] . These suggest that HOX genes are important in vertebral development and abnormal expression of these genes as we observed in AIS patients could play a role in curvation of the spine.
PITX1 (pituitary homeobox 1) gene encodes for a protein that is a member of RIEG/PITX homeobox family with transcriptional properties that have been defined for number of late downstream target genes in the pituitary gland [22] . As a member of this family, PITX1 gene is involved in limb and organ development and in left-right asymmetry [23] . The down-regulated expression of PITX1 in our study confirms that this protein plays a crucial role in bone The 46 genes that were clustered by the DAVID algorithm are listed in their five gene cluster groupings with gene enrichment scores, with associated fold-changes per gene. Gene cluster analysis of differentially regulated genes in primary human osteoblasts. Up-regulated genes are shown in red, Down-regulated genes are shown in green development and probably in AIS. Furthermore, Cartilage oligomeric matrix protein (COMP) is a novel gene to consider in the context of AIS pathogenesis. This gene is essential for the normal development of cartilage and for its conversion to bone during growth. For instance, COMP also interacts with the transcription factor SOX-9, which plays an important role in normal skeletal development. Mutations in COMP produce clinical phenotypes of pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED). These disorders are characterized by disproportionate short stature, brachydactyly, joint hyper-mobility, early-onset osteoarthritis, and scoliosis [24] . Consistent with our study, COMP was recently found to be down-regulated by fourfold in AIS compared to unaffected individuals and it was proposed as an important and novel biomarker in predicting scoliosis development [25] . Interestingly, COMP and HOXA10 interact closely in embryonic limb morphogenesis (GO: 0030326. http://amigo.geneontology.org) and with ERAP2; which is associated with familial ankylosing spondylitis and it affects joints and can cause eventual fusion of the spine [26] . Altogether, these data suggest that low expression of COMP and its molecular interactions are associated with AIS. Other modulated genes in our experiment include BST2, HCLS1, TBX15, PCDH10 and GDF15. Although these genes are not directly involved in bone and cartilage development, they are involved in immune process and Wnt, tyrosine kinase signaling pathways that are important in the embryonic development and may be associated with AIS.
Our study screened candidate genes that may contribute to the pathogenesis of AIS, and provided a new list of genes that merit further investigation. such as the epigenetic interactions (that could modify the expression of specific genes) as well as the identification of variants in these genes, as possible AIS contributing genes. We found that the gene expression patterns of primary osteoblasts derived from spinal vertebrae of AIS patients were different from those of healthy individuals. Gene mutations can affect gene transcripts. In addition, the expression of specific genes by cells can be modified by various ways: enzymes methylate DNA to modulate transcription, histone modification resulting in inducing or repression of target sequences, non-coding small RNA which could attach to messengers RNA to modify gene expression of specific genes [27, 28] . Therefore, it is likely that these mechanisms might play an important role in the altered gene expression patterns in AIS osteoblasts. Genes with altered expression in AIS could be grouped into specific subsets based on their biological functions and gene-gene interactions, suggesting the possible involvement of various pathways in AIS pathogenesis. Interestingly, patients with AIS with similar gene profiles may have varying severity of spinal curve suggesting that genetic factors likely control disease susceptibility and course, but not disease pattern. Hormonal and environmental factors may also affect the clinical phenotype and the severity of curve [29] although patients may have the similar gene profiles but this area remains unexplored and beyond the scope of this study. Taken together our study revealed gene expression changes in AIS osteoblasts. These findings help to gain further insights into potential genes and molecular pathways that could contribute to understanding the pathophysiology of idiopathic scoliosis. Furthermore, although bone contributes significantly in developing AIS, the intervertebral discs (IVD) and muscles also have significant mechanisms in the pathogenesis of AIS. Therefore, our approach can be helpful to study the gene expression profile of AIS IVD and muscles and to further add to our understanding of AIS etiology. Identification of the underlying mechanisms that leads to the observed clinical features of scoliosis remains the crucial next step to further advance understanding of AIS pathogenesis.
